NASDAQ:EVAX
Evaxion Biotech A/S
- Stock
Last Close
2.91
26/07 20:00
Market Cap
16.59M
Beta: 0.56
Volume Today
11.28K
Avg: 118.15K
PE Ratio
−0.47
PFCF: 6.47
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -5.54M - | -11.20M 102.26% | -15.02M 34.15% | -24.53M 63.35% | -23.17M 5.56% | -22.16M 4.36% | |
depreciation and amortization | 74K - | 81K 9.46% | 105K 29.63% | 344K 227.62% | 571K 65.99% | 615.95K 7.87% | |
deferred income tax | -735K - | -825K 12.24% | -2.07M 150.55% | -190K 90.81% | -998K 425.26% | ||
stock based compensation | 2.07M - | 2.36M 14.16% | 3.41M 44.28% | 1.38M 59.54% | 942K 31.69% | ||
change in working capital | 981K - | 566K 42.30% | 215K 62.01% | 1.24M 475.35% | -2.88M 332.58% | 1.56M 154.38% | |
accounts receivables | 443K - | -337K 176.07% | -2.52M 647.22% | 1.86M 173.87% | -1.49M 179.94% | 1.11M 174.57% | |
inventory | 446K - | 403K 9.64% | 2.52M 524.85% | -1.86M 173.87% | 1.49M 179.94% | 1 100.00% | |
accounts payables | 79K - | 507K 541.77% | 1.80M 254.64% | -647K 135.98% | -599K 7.42% | 502.77K 183.94% | |
other working capital | 13K - | -7K 153.85% | -1.58M 22,514.29% | 1.88M 219.01% | -2.28M 220.91% | -47.07K 97.93% | |
other non cash items | 1.16M - | 1.99M 71.86% | 919K 53.70% | -171K 118.61% | -243K 42.11% | 2.26M 1,030.24% | |
net cash provided by operating activities | -1.99M - | -7.03M 252.89% | -12.44M 77.03% | -21.93M 76.34% | -25.77M 17.51% | -17.72M 31.26% | |
investments in property plant and equipment | -7K - | -61K 771.43% | -393K 544.26% | -1.36M 246.06% | -292K 78.53% | -87.13K 70.16% | |
acquisitions net | |||||||
purchases of investments | -6.01K - | ||||||
sales maturities of investments | 29.95K - | 24.01K 19.83% | |||||
other investing activites | 13K - | 48 - | -13 127.08% | -0.76 94.12% | |||
net cash used for investing activites | 6K - | -61K 1,116.67% | -393K 544.26% | -1.33M 238.42% | -268K 79.85% | -93.14K 65.25% | |
debt repayment | -63K - | -73K 15.87% | -74K 1.37% | -289K 290.54% | -424K 46.71% | -306.47K 27.72% | |
common stock issued | 1.09M - | 9.44M 764.65% | 9.02M 4.47% | 53.85M 497.05% | 428K 99.21% | 11.34M 2,549.63% | |
common stock repurchased | -13K - | ||||||
dividends paid | -165K - | ||||||
other financing activites | 8.00M - | 317K 96.04% | -128K 140.38% | -3.76M 2,837.50% | 7.85M 308.75% | -326.50K 104.16% | |
net cash used provided by financing activities | 9.03M - | 9.51M 5.33% | 8.82M 7.26% | 49.80M 464.81% | 7.85M 84.23% | 10.71M 36.35% | |
effect of forex changes on cash | -77K - | -295K 283.12% | 288K 197.63% | -210K 172.92% | -793K 277.62% | -497.59K 37.25% | |
net change in cash | 6.96M - | 2.13M 69.48% | -3.73M 275.21% | 26.33M 806.90% | -18.98M 172.09% | -7.60M 59.95% | |
cash at beginning of period | 468K - | 7.43M 1,488.25% | 9.56M 28.60% | 5.83M 38.97% | 32.17M 451.35% | 13.18M 59.01% | |
cash at end of period | 7.43M - | 9.56M 28.60% | 5.83M 38.97% | 32.17M 451.35% | 13.18M 59.01% | 5.58M 57.65% | |
operating cash flow | -1.99M - | -7.03M 252.89% | -12.44M 77.03% | -21.93M 76.34% | -25.77M 17.51% | -17.72M 31.26% | |
capital expenditure | -7K - | -61K 771.43% | -393K 544.26% | -1.36M 246.06% | -292K 78.53% | -87.13K 70.16% | |
free cash flow | -2.00M - | -7.09M 254.70% | -12.83M 81.05% | -23.29M 81.54% | -26.07M 11.90% | -17.81M 31.69% |
All numbers in USD (except ratios and percentages)